Statistics
Publications
1
Citations
270
H-Index
1
Active since
2000
Affiliations
Novartis (Switzerland)(Current)
D Fabbro is an author at Novartis (Switzerland) specializing in tumor microenvironment, radiation oncology, and tumor biology.
Publications per year
2000–2000
1
1
PKC412--a protein kinase inhibitor with a broad therapeutic potential.
D Fabbro, Stephan Ruetz, Stephan Bodis et al. · PubMed · 2000 · 270 citations
Chemoprevention Strategy, Metronomic Chemotherapy, Tumor Biology +17
1–1 of 1